Metastatic Disease Clinical Trial Setting

Known as: METASTATIC 
A clinical trial or treatment setting in which the therapy of interest is used to treat metastatic disease.
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SDTM Treatment Setting TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
BACKGROUND Prostate cancer (PCa) is the second most common disease among men worldwide. It is important to know survival outcomes… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2015
2015
MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1
Metastasis is a leading cause of mortality for osteosarcoma patients. The molecular pathological mechanism remains to be… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
BACKGROUND Vismodegib, a first-in-class Hedgehog pathway inhibitor, was US Food and Drug Administration (FDA) approved for… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Is this relevant?
2013
2013
Segmentation, Feature Extraction, and Multiclass Brain Tumor Classification
Multiclass brain tumor classification is performed by using a diversified dataset of 428 post-contrast T1-weighted MR images from… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.
PURPOSE We evaluated the feasibility of administering carboplatin as a radiosensitizer during craniospinal radiation therapy… (More)
Is this relevant?
2006
2006
Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE.
PURPOSE Despite stage migration as a result of screening, many individuals are diagnosed each year with metastatic (M+), as… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
Little is known about the genetic regulation of medulloblastoma dissemination, but metastatic medulloblastoma is highly… (More)
  • figure 1
Is this relevant?
1998
1998
Elevated c-Src protein expression is an early event in colonic neoplasia.
The molecular events regulating the development and progression of colonic neoplasia are currently being delineated. Recent… (More)
Is this relevant?
1996
1996
Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression.
BACKGROUND & AIMS Scarce biological information exists about the importance of preneoplastic lesions in gallbladder cancer. The… (More)
Is this relevant?
1991
1991
Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.
Undifferentiated nasopharyngeal carcinoma (UCNT) is known to be radiosensitive and chemosensitive, but the latter has never been… (More)
Is this relevant?